PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 50 filers reported holding PASSAGE BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,508 | -30.1% | 123,873 | 0.0% | 0.00% | – |
| Q2 2023 | $116,602 | -1.7% | 123,873 | 0.0% | 0.00% | – |
| Q1 2023 | $118,633 | -65.3% | 123,873 | -50.0% | 0.00% | – |
| Q4 2022 | $341,890 | +120.6% | 247,746 | +100.0% | 0.00% | – |
| Q3 2022 | $155,000 | -46.9% | 123,873 | 0.0% | 0.00% | – |
| Q2 2022 | $292,000 | -87.6% | 123,873 | -83.7% | 0.00% | – |
| Q1 2022 | $2,357,000 | -48.2% | 760,352 | +6.1% | 0.00% | – |
| Q4 2021 | $4,551,000 | -33.1% | 716,633 | +5.0% | 0.00% | – |
| Q3 2021 | $6,799,000 | -71.9% | 682,627 | -62.7% | 0.00% | -100.0% |
| Q2 2021 | $24,238,000 | -22.3% | 1,830,649 | +2.5% | 0.00% | -50.0% |
| Q1 2021 | $31,206,000 | +209.8% | 1,785,237 | +353.2% | 0.00% | +100.0% |
| Q4 2020 | $10,072,000 | +233.7% | 393,916 | +71.1% | 0.00% | – |
| Q3 2020 | $3,018,000 | -44.5% | 230,211 | +15.7% | 0.00% | – |
| Q2 2020 | $5,438,000 | – | 198,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |